Race Oncology Ltd (RAC) - Total Liabilities

Latest as of December 2025: AU$1.20 Million AUD ≈ $847.04K USD

Based on the latest financial reports, Race Oncology Ltd (RAC) has total liabilities worth AU$1.20 Million AUD (≈ $847.04K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Race Oncology Ltd to track the company's year-over-year net asset growth rate.

Race Oncology Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Race Oncology Ltd's total liabilities have evolved over time, based on quarterly financial data. See RAC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Race Oncology Ltd Competitors by Total Liabilities

The table below lists competitors of Race Oncology Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Eaton Vance Floating Rate Income Closed Fund NYSE:EFT	USA	$194.26 Million
Foghorn Therapeutics Inc NASDAQ:FHTX	USA	$306.60 Million
Legato Merger Corp. III NYSE MKT:LEGT	USA	$7.04 Million
Kogeneracja SA WAR:KGN	Poland	zł2.21 Billion
Southeast Cement Co Ltd TW:1110	Taiwan	NT$3.13 Billion
Egis Technology TWO:6462	Taiwan	NT$5.77 Billion
Grupo Gicsa S.A. de C.V MX:GICSAB	Mexico	MX$40.52 Billion
Soyea Technology Co Ltd SHE:000909	China	CN¥1.30 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Race Oncology Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Race Oncology Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	18.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Race Oncology Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Race Oncology Ltd (2011–2025)

The table below shows the annual total liabilities of Race Oncology Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.48 Million ≈ $1.05 Million	-22.85%
2024-06-30	AU$1.92 Million ≈ $1.36 Million	+66.39%
2023-06-30	AU$1.15 Million ≈ $814.97K	-18.74%
2022-06-30	AU$1.42 Million ≈ $1.00 Million	+170.95%
2021-06-30	AU$523.11K ≈ $370.13K	+114.70%
2020-06-30	AU$243.65K ≈ $172.40K	+26.82%
2019-06-30	AU$192.12K ≈ $135.94K	-37.97%
2018-06-30	AU$309.71K ≈ $219.14K	-14.82%
2017-06-30	AU$363.57K ≈ $257.25K	-7.16%
2016-06-30	AU$391.62K ≈ $277.10K	+229.70%
2015-06-30	AU$118.78K ≈ $84.04K	-10.05%
2014-06-30	AU$132.05K ≈ $93.43K	-99.93%
2013-12-31	AU$191.01 Million ≈ $135.15 Million	+1611781.86%
2013-06-30	AU$11.85K ≈ $8.38K	-100.00%
2012-12-31	AU$264.98 Million ≈ $187.49 Million	-20.07%
2012-06-30	AU$331.51 Million ≈ $234.56 Million	+21.34%
2011-06-30	AU$273.20 Million ≈ $193.31 Million	--

About Race Oncology Ltd

AU:RAC Australia Biotechnology

Market Cap

$285.79 Million

AU$403.90 Million AUD

Market Cap Rank

#15067 Global

#412 in Australia

Share Price

AU$2.06

Change (1 day)

+4.83%

52-Week Range

AU$1.16 - AU$4.70

All Time High

AU$4.70